Company
Headquarters: New Taipei City, Taiwan
TW$2.06 Billion
TWD as of Jan. 1, 2024
US$67.2 Million
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $204.45 B |
| Danaher | $177.21 B |
| Siemens Healthineers AG | $63.84 B |
| DexCom, Inc. | $45.21 B |
| Lonza Group Ltd | $39.85 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Kim Forest Enterprise Co., Ltd. provides precision medical products. It offers devices, reagents, and analysis pipelines to health care providers, which include screening tests for cancer and inherited diseases. The company also provides genetic testing, drug report, and monitoring tools for cancer patients; and a non-invasive genome-wide health assessment for healthy persons. In addition, it offers bioinformatics service items; prenatal test kits; and genetically modified models. Further, the company offers SARS-CoV-2 detection kits. The company was founded in 2004 and is based in New Taipei City, Taiwan.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Kim Forest Enterprise Co. Ltd has the following listings and related stock indices.
Stock: TWSE: 6645 wb_incandescent